395 related articles for article (PubMed ID: 31082342)
1. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
[No Abstract] [Full Text] [Related]
2. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
3. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
4. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
5. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis.
Han E; Jo SJ; Lee H; Choi AR; Lim J; Jung ES; Oh EJ
Clin Chim Acta; 2017 Jan; 464():113-117. PubMed ID: 27864100
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity].
Tang YM; Bao WM; You LY; Jiang HJ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):359-62. PubMed ID: 24025137
[TBL] [Abstract][Full Text] [Related]
9. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
[TBL] [Abstract][Full Text] [Related]
10. Detection of AMA-M2 in human saliva: Potentials in diagnosis and monitoring of primary biliary cholangitis.
Lu C; Hou X; Li M; Wang L; Zeng P; Jia H; Chen J; Wei Y; He H; Liu X; Diao H
Sci Rep; 2017 Apr; 7(1):796. PubMed ID: 28400582
[TBL] [Abstract][Full Text] [Related]
11. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis?
Sánchez-Pobre P; Castellano G; Colina F; Dominguez P; Rodriguez S; Canga F; Herruzo JA
J Clin Gastroenterol; 1996 Oct; 23(3):191-8. PubMed ID: 8899500
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
14. [The value of antimitochondrial antibody and its subtypes in the diagnosis of primary biliary cirrhosis].
Yao DK; Xie WF; Chen WZ; Liu HY; Tu XQ; Fan LY
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):9-11. PubMed ID: 15670482
[TBL] [Abstract][Full Text] [Related]
15. Anti-mitochondrial antibodies detection assays for diagnosis of primary biliary cholangitis in southern Tunisia population.
Mejdoub S; Hamza Z; Hachicha H; Chtourou L; Marrzouk S; Feki S; Jerbi A; Boukthir S; Bahloul Z; Tahri N; Masmoudi H
Ann Biol Clin (Paris); 2022 Sep; 80(5):423-429. PubMed ID: 36453746
[TBL] [Abstract][Full Text] [Related]
16. High sensitivity of a novel ELISA for anti-M2 in primary biliary cirrhosis.
Miyakawa H; Kikuchi K; Jong-Hon K; Kawaguchi N; Yajima R; Ito Y; Maekubo H
J Gastroenterol; 2001 Jan; 36(1):33-8. PubMed ID: 11211208
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
Xiao H; Chen JW; Xie X; Liu YM; Li F
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome].
Tan XY; Miao Q; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):376-380. PubMed ID: 31177663
[No Abstract] [Full Text] [Related]
19. [Clinical features of patients with primary biliary cirrhosis].
He L; Lai Y; Lai L; Luo K; Wang W; Tian Y; Gong G; Zhang M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1333-9. PubMed ID: 26739075
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
